A pharmacy has been ordered to recall unregistered weight-loss medicines after regulatory raid.
THE South African Health Products Regulatory Authority (SAHPRA) and the South African Pharmacy Council (SAPC) have launched a crackdown on the illegal manufacturing and distribution of unregistered weight-loss medicines containing semaglutide and tirzepatide, following a significant raid at a pharmacy that revealed serious regulatory violations.
A joint investigation conducted at iDexis (Pty) Ltd, trading as Sentra Pharmacy in Silverton, Pretoria, on May 11, resulted in the seizure of all injectable GLP-1 and GIP products found on site after authorities uncovered what they described as critical non-compliance with South African medicines laws, IOL reported.
The inspection focused on medicines containing semaglutide, tirzepatide, and combination formulations marketed for weight loss.
"The investigation revealed that the company was producing and supplying medicines under the pretext of 'compounding', but outside the legal framework permitted under South African law," said SAHPRA.
